Providers can verify compliance by checking the pharmacys license with the state board of pharmacy, confirming they require patient-specific prescriptions, and requesting to see the Certificate of Analysis (COA) for the active ingredient
Studies have shown that the dual inhibitor CUDC-907 (10 nM) effectively inhibits myeloma cell growth and downregulates anti-apoptotic proteins (Bcl-xL, MCL-1) at lower concentrations by simultaneously targeting HDAC and PI3K
The approval is based on the Phase III JUPITER-02 study where Loqtorzi combined with chemotherapy significantly improved progression-free survival, reducing the risk of disease progression or death by 48% compared to chemo alone
It plays a central role in cellular detoxification, the neutralisation of reactive oxygen species, and the regeneration of other antioxidants including Vitamins C and E
Tatiomax Products stand at the forefront of health and beauty, offering scientifically backed solutions that deliver real results